Clément Dumont

4PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 08, 2026
ILT2 identifies an unexploited pool of intratumoral CD8+ bystander T cells with TCR-independent cytotoxicity in renal cell carcinoma.

|Aug 09, 2023
Safety and efficacy of preoperative chemotherapy for muscle-invasive bladder cancer in elderly patients.

Clément Dumont, Amélie Aregui, Mathilde Hauchecorne

|Feb 25, 2023
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.

Pauline Parent, Edouard Auclin, Anna Patrikidou

|Sep 23, 2022
Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study.

Diane Evrard, Clément Dumont, Michel Gatineau

Pageof 1

Frequent Collaborators

1 joint publications

Jérôme Fayette

1 joint publications

Christophe Le Tourneau

1 joint publications

Pauline Parent

1 joint publications

Alejo Rodriguez-Vida